Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8790049 | Urologic Oncology: Seminars and Original Investigations | 2018 | 12 Pages |
Abstract
ACSS2 may increase tumor progression and aggressive behavior and be an independent prognostic factor in RCC.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Shaojin M.D., Juanjuan M.D., Zhankui M.D., Zechen M.D., Jinjian M.D.,